| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/25/2002 | US20020098213 Use of ellagic acid and its derivatives in cosmetics and dermatology |
| 07/25/2002 | US20020098211 Comprising at least one polyol and 2-hydroxy-4-(1-methylethyl)cyclohepta-2 4 6-trier-1-one or sodium capryl lactyl lactylate |
| 07/25/2002 | US20020098207 Cholesterol sulfate compositions for enhancement of stratum corneum function |
| 07/25/2002 | US20020098201 Novel myxoma genes for immune modulation |
| 07/25/2002 | US20020098166 Genetically modified cells and their use in the prophylaxis or therapy of disorders |
| 07/25/2002 | US20020098159 Surfactants and organic and/or inorganic acids |
| 07/25/2002 | DE10056059A1 Differenzierung auslösende Substanzen Differentiation-inducing substances |
| 07/25/2002 | CA2443080A1 Lipid-based nitric oxide donors |
| 07/25/2002 | CA2435260A1 Receptors and membrane-associated proteins |
| 07/25/2002 | CA2435248A1 Drug composition for the promotion of tissue regeneration |
| 07/25/2002 | CA2435069A1 Treatment solution for taking care of wounds and dressing material to be used together with said treatment solution |
| 07/25/2002 | CA2434939A1 Urea derivatives as integrin alpha 4 antagonists |
| 07/25/2002 | CA2434866A1 Screening assay for cotranslational translocation interfering compounds |
| 07/25/2002 | CA2434636A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 07/25/2002 | CA2433879A1 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/25/2002 | CA2433313A1 Polypetides and nucleic acids encoding same |
| 07/25/2002 | CA2430634A1 Proteins, polynucleotides encoding them and methods of using the same |
| 07/24/2002 | EP1225183A2 Human G-protein coupled receptor |
| 07/24/2002 | EP1224944A1 Skin immune function controlling agents |
| 07/24/2002 | EP1224941A2 Antithrombin III used in diseases caused by angiogenesis |
| 07/24/2002 | EP1224938A1 Gugulipid for treating cognitive disorders, hyperglycaemia and skin disorders |
| 07/24/2002 | EP1224937A1 Stable preparations for treating bedsore, skin ulcer and wound |
| 07/24/2002 | EP1224931A1 Use of alkanoyloxymethyl esters for inhibiting histone deacetylase |
| 07/24/2002 | EP1224322A2 Gene sequence variations with utility in determining the treatment of disease |
| 07/24/2002 | EP1224288A2 Processed human chemokines phc-1 and phc-2 |
| 07/24/2002 | EP1224285A2 27 human secreted proteins |
| 07/24/2002 | EP1224282A2 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 07/24/2002 | EP1224281A1 37 human secreted proteins |
| 07/24/2002 | EP1224218A1 Dna encoding human alpha1g-c t-type calcium channel |
| 07/24/2002 | EP1224203A2 Antisense modulation of protein kinase c-theta expression |
| 07/24/2002 | EP1224202A1 Antisense modulation of integrin-linked kinase expression |
| 07/24/2002 | EP1224201A1 32 human secreted proteins |
| 07/24/2002 | EP1224200A1 Tissue plasminogen activator-like protease |
| 07/24/2002 | EP1224195A1 C-aryl glucoside sglt2 inhibitors |
| 07/24/2002 | EP1224180A2 Substituted azoles |
| 07/24/2002 | EP1224171A1 Beta disubstituted metalloprotease inhibitors |
| 07/24/2002 | EP1224170A1 6-position substituted indoline, production and use thereof as a medicament |
| 07/24/2002 | EP1224022A1 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 07/24/2002 | EP1223988A1 Antisense modulation of tumor necrosis factor alpha converting enzyme (tace) expression |
| 07/24/2002 | EP1223974A2 Medicament in order to induce tolerance |
| 07/24/2002 | EP1223966A2 Use of gdnf for treating corneal defects |
| 07/24/2002 | EP1223962A1 Method and compositions for inhibiting adhesion formation |
| 07/24/2002 | EP1223950A2 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 07/24/2002 | EP1223945A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 07/24/2002 | EP1223932A1 Compounds and methods |
| 07/24/2002 | EP1223913A2 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 07/24/2002 | EP1223809A1 Methods of treating hair loss comprising administering indoline compound |
| 07/24/2002 | EP1185260A4 Ascorbic acid composition and method for treatment of aging or damaged skin |
| 07/24/2002 | EP1146886B1 Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition |
| 07/24/2002 | EP1102743B1 Amide derivatives which are useful as cytokine inhibitors |
| 07/24/2002 | EP1100767B1 Novel phenylethylamine derivatives, a method for the production thereof and their use as medicaments |
| 07/24/2002 | EP1059934B1 Matrix protein compositions for wound healing |
| 07/24/2002 | CN1360596A Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 07/24/2002 | CN1360582A Quinazoline derivs. |
| 07/24/2002 | CN1360581A Benzoylpyridazines |
| 07/24/2002 | CN1360577A Hydroxamic acid derivs. as matrix metalloprotease inhibitors |
| 07/24/2002 | CN1360572A Vitamin D3 Analogs |
| 07/24/2002 | CN1360509A Herb medicine composition to be contained in sanitary materials for infants |
| 07/24/2002 | CN1360507A Conjugates and method for production thereof, and their use for transporting molecules via biological membranes |
| 07/24/2002 | CN1360467A Antimicrobial sanitizing lotion with skin protection properties |
| 07/24/2002 | CN1359728A Medicine for treating wart |
| 07/24/2002 | CN1359724A Medicine for treating burn and scald |
| 07/24/2002 | CN1359719A Application of tea in preparing exterior-applied medicine of treating dermatopathy |
| 07/24/2002 | CN1359718A Chinese medicine for treating burn and scald and its preparing process |
| 07/24/2002 | CN1359716A Chinese-medicinal oral liquid for treating flat wart |
| 07/24/2002 | CN1359714A Medicine for treating dermatopathy |
| 07/24/2002 | CN1359712A Powdered Chinese medicine for treating burn and scald |
| 07/24/2002 | CN1359710A Chinese medicine for treating dermatopathy and venereal disease and its preparing process |
| 07/24/2002 | CN1359701A Aloe wine for treating injury |
| 07/24/2002 | CN1359675A Use of benzodihydropyran deriv. in beauty or dermatology preparation |
| 07/24/2002 | CN1088068C Ascomycins |
| 07/24/2002 | CN1087950C Dermatosis treating Chinese medicine and its preparation method |
| 07/24/2002 | CN1087948C Burn and scald treating liquid |
| 07/24/2002 | CN1087929C Whitening beauty and skin-protecting cream |
| 07/23/2002 | US6423855 Prevention lysis; oxidation resistance |
| 07/23/2002 | US6423753 Controlling angiogenesis |
| 07/23/2002 | US6423750 Systems for delivering anti-infective compositions to treat disordered tissue such as cold sores |
| 07/23/2002 | US6423747 Cosmetic and dermatological preparations with flavonoids |
| 07/23/2002 | US6423712 2,4-Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 07/23/2002 | US6423710 Cyclic AMP-specific phosphodiesterase inhibitors |
| 07/23/2002 | US6423708 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/23/2002 | US6423521 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/23/2002 | US6423333 Sealing or filling tissue defects using polyfunctional crosslinking agents and protein polymers |
| 07/23/2002 | US6423327 Treating wrinkles of skin with adenosine |
| 07/23/2002 | CA2365997A1 Novel polypeptide |
| 07/23/2002 | CA2256348C Method of improving skin condition |
| 07/23/2002 | CA2058597C Wound healing compositions containing fibroblast growth factor and ascorbic acid |
| 07/18/2002 | WO2002055705A2 Proteins and nucleic acids encoding same |
| 07/18/2002 | WO2002055698A2 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 07/18/2002 | WO2002055676A2 Method for processing dendritic cells and for activating macrophages with ru 41740 |
| 07/18/2002 | WO2002055541A2 Peptides having inhibiting activity on the production of nitric oxide |
| 07/18/2002 | WO2002055540A1 New retinol derivatives, the method of preparations and the uses thereof |
| 07/18/2002 | WO2002055531A1 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 07/18/2002 | WO2002055525A1 Retinoid agonists |
| 07/18/2002 | WO2002055518A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists |
| 07/18/2002 | WO2002055517A2 4-(hetero)aryl substituted indolinones |
| 07/18/2002 | WO2002055510A1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 07/18/2002 | WO2002055507A1 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors |
| 07/18/2002 | WO2002055506A1 Preventive or remedial agent for allergic disease and medical water-based liquid preparation, eye drop, and nasal drop |
| 07/18/2002 | WO2002055501A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |